{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:38:23Z","timestamp":1793417903700,"version":"4.5.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>This study analyzed the association between anti-Ro\/SSA and anti-La\/SSB antibody levels with quantitative and visual sialoscintigraphy patterns in patients suspected of having Sj\u00f6gren or sicca syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>Medical records of patients who underwent sialoscintigraphy between April 2020 and May 2022 were reviewed. Associations between antibody levels and sialoscintigraphy parameters were evaluated using linear regression. Receiver operating characteristic curve analysis was used to identify antibody cutoff values for predicting flat-type patterns and the risk of Sj\u00f6gren or sicca syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 170 patients (mean age, 56.6 years; 78.8% female), 95.3% had dry mouth and eyes, 30% experienced polyarthralgia, and 66.5% were prescribed hydroxychloroquine. The most common sialoscintigraphy finding was the median-type time-activity curve (TAC) pattern. Anti-Ro\/SSA and anti-La\/SSB levels were significantly correlated with maximum accumulation or maximum secretion in the salivary glands. Receiver operating characteristic analysis for anti-Ro\/SSA predicting a flat-type TAC pattern showed an area under the curve (AUC) of 0.659 to 0.780, with specificity between 82.1% and 86.3% for antibody levels greater than 85.2 units. Anti-Ro\/SSA levels greater than 49.75 units predicted a higher risk of Sj\u00f6gren or sicca syndrome, with an AUC of 0.622 and 83.9% specificity. Anti-La\/SSB levels had no significant predictive value, with an AUC of 0.554.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Anti-Ro\/SSA levels greater than 85.2 units were strong predictors of flat-type TAC patterns, indicating near-total salivary gland dysfunction and supporting their diagnostic utility in Sj\u00f6gren or sicca syndrome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000005602","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T18:06:20Z","timestamp":1733249180000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Quantitative Sialoscintigraphy and Antibody Profiles in Patients With Sj\u00f6gren or Sicca Syndrome"],"prefix":"10.1097","author":[{"given":"Tzyy-Ling","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Koo","sequence":"additional","affiliation":[{"name":"Department of Nursing, Tzu Chi University, Hualien"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5323-049X","authenticated-orcid":false,"given":"Yi-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1234-6263","authenticated-orcid":false,"given":"Chien-Hsueh","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"bib1-20241203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"bib2-20241203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sjogren's syndrome: a systemic autoimmune disease","volume":"22","year":"2022","journal-title":"Clin Exp Med"},{"key":"bib3-20241203","doi-asserted-by":"crossref","first-page":"777599","DOI":"10.3389\/fmed.2021.777599","article-title":"Multimodal assessment and characterization of sicca syndrome","volume":"8","year":"2021","journal-title":"Front Med"},{"key":"bib4-20241203","first-page":"e12996","article-title":"Not all sicca is Sjogren's and not all Sjogren's is sicca","volume":"13","year":"2021","journal-title":"Cureus"},{"key":"bib5-20241203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2019.04.009","article-title":"Sjogren's syndrome: an update on disease pathogenesis, clinical manifestations and treatment","volume":"203","year":"2019","journal-title":"Clin Immunol"},{"key":"bib6-20241203","first-page":"606195","article-title":"Clinical and pathological roles of Ro\/SSA autoantibody system","volume":"2012","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"bib7-20241203","doi-asserted-by":"crossref","first-page":"103013","DOI":"10.1016\/j.autrev.2021.103013","article-title":"An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management","volume":"21","year":"2022","journal-title":"Autoimmun Rev"},{"key":"bib8-20241203","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bjo.2003.028340","article-title":"Anti-Ro\/SSA and anti-La\/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome","volume":"88","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"bib10-20241203","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1034\/j.1601-0825.2001.70207.x","article-title":"Periodontal disease in primary Sjogren's syndrome","volume":"7","year":"2001","journal-title":"Oral Dis"},{"key":"bib11-20241203","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11926-003-0009-5","article-title":"The oral component of Sjogren's syndrome: pass the scalpel and check the water","volume":"5","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"bib12-20241203","first-page":"911","article-title":"Oral candidiasis and Sjogren's syndrome","volume":"25","year":"1998","journal-title":"J Rheumatol"},{"key":"bib13-20241203","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1834-7819.2010.01229.x","article-title":"Xerostomia: an update for clinicians","volume":"55","year":"2010","journal-title":"Aust Dent J"},{"key":"bib14-20241203","first-page":"e14","article-title":"Risk factors, hyposalivation and impact of xerostomia on oral health-related quality of life","volume":"31","year":"2017","journal-title":"Braz Oral Res"},{"key":"bib15-20241203","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/jama.1971.03180390021005","article-title":"Xerostomia in Sjogren's syndrome. Evaluation by sequential salivary scintigraphy","volume":"216","year":"1971","journal-title":"JAMA"},{"key":"bib16-20241203","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/bdjteam.2018.26","article-title":"Facilitating timely diagnosis of Sj\u00f6gren's syndrome","volume":"5","year":"2018","journal-title":"BDJ Team"},{"key":"bib17-20241203","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.otot.2008.10.007","article-title":"Labial minor salivary gland biopsy","volume":"19","year":"2008","journal-title":"Oper Tech Otolaryngol Head Neck Surg"},{"key":"bib18-20241203","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jfma.2019.06.012","article-title":"Application of classification criteria of Sjogren syndrome in patients with sicca symptoms: real-world experience at a medical center","volume":"119","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"bib19-20241203","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.autrev.2009.02.027","article-title":"Assessment of salivary gland function in Sjogren's syndrome: the role of salivary gland scintigraphy","volume":"8","year":"2009","journal-title":"Autoimmun Rev"},{"key":"bib20-20241203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3413\/Nukmed-0630-13-10","article-title":"Salivary gland scintigraphy in Sjogren's syndrome. Comparison of the diagnostic performance of visual and semiquantitative analysis","volume":"53","year":"2014","journal-title":"Nuklearmedizin"},{"key":"bib21-20241203","first-page":"e3","article-title":"Diagnostic approaches to Sjogren's syndrome: a literature review and own clinical experience","volume":"3","year":"2012","journal-title":"J Oral Maxillofac Res"},{"key":"bib22-20241203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cpf.12199","article-title":"Imaging of the major salivary glands","volume":"36","year":"2016","journal-title":"Clin Physiol Funct Imaging"},{"key":"bib23-20241203","first-page":"45","article-title":"Schirmer's test","volume":"24","year":"2011","journal-title":"Community Eye Health"},{"key":"bib24-20241203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"bib25-20241203","first-page":"64","article-title":"Quantitative evaluation of salivary gland scintigraphy in Sjogren's syndrome","volume":"40","year":"1999","journal-title":"J Nucl Med"},{"key":"bib26-20241203","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF02984967","article-title":"Scoring analysis of salivary gland scintigraphy in patients with Sjogren's syndrome","volume":"17","year":"2003","journal-title":"Ann Nucl Med"},{"key":"bib27-20241203","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/ard.2004.031781","article-title":"Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjogren's syndrome compared with non-Sjogren's sicca syndrome","volume":"64","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"bib28-20241203","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/ar2958","article-title":"Anticentromere antibody positive Sjogren's syndrome: a retrospective descriptive analysis","volume":"12","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"bib29-20241203","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1155\/2013\/726598","article-title":"Rheumatoid factors: clinical applications","volume":"35","year":"2013","journal-title":"Dis Markers"},{"key":"bib30-20241203","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1038\/s41598-018-24279-1","article-title":"Clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sjogren's syndrome","volume":"8","year":"2018","journal-title":"Sci Rep"},{"key":"bib31-20241203","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10067-005-0059-3","article-title":"Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome: prevalence and clinical significance in 335 patients","volume":"25","year":"2006","journal-title":"Clin Rheumatol"},{"key":"bib32-20241203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2012.03.001","article-title":"Subgroups of Sjogren syndrome patients according to serological profiles","volume":"39","year":"2012","journal-title":"J Autoimmun"},{"key":"bib33-20241203","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI114968","article-title":"Protein heterogeneity in the human Ro\/SSA ribonucleoproteins. The 52- and 60-kD Ro\/SSA autoantigens are encoded by separate genes","volume":"87","year":"1991","journal-title":"J Clin Invest"},{"key":"bib34-20241203","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/acr.24597","article-title":"Antibodies to both Ro52 and Ro60 for identifying Sjogren's syndrome patients best suited for clinical trials of disease-modifying therapies","volume":"74","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"bib35-20241203","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/08916934.2012.732131","article-title":"Clinical associations of anti-SSA\/Ro60 and anti-Ro52\/TRIM21 antibodies: diagnostic utility of their separate detection","volume":"46","year":"2013","journal-title":"Autoimmunity"},{"key":"bib36-20241203","first-page":"686","article-title":"Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjogren's syndrome","volume":"30","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"bib37-20241203","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00296-017-3715-4","article-title":"Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjogren's syndrome : a long-term study of the Antonius Nieuwegein Sjogren (ANS) cohort","volume":"37","year":"2017","journal-title":"Rheumatol Int"},{"key":"bib38-20241203","first-page":"157","article-title":"A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience","volume":"14","year":"2014","journal-title":"Clin Med (Lond)"},{"key":"bib39-20241203","doi-asserted-by":"crossref","first-page":"105544","DOI":"10.1016\/j.jbspin.2023.105544","article-title":"Prevalence and comorbidities of Sjogren's syndrome patients in the community of Madrid: a population-based cross-sectional study","volume":"90","year":"2023","journal-title":"Joint Bone Spine"},{"key":"bib40-20241203","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.rdc.2008.08.011","article-title":"Role of nuclear scintigraphy in the characterization and management of the salivary component of Sjogren's syndrome","volume":"34","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"bib41-20241203","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00006231-199912000-00004","article-title":"Scintigraphic features of chronic sialadenitis and Sjogren's syndrome: a comparison","volume":"20","year":"1999","journal-title":"Nucl Med Commun"},{"key":"bib42-20241203","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00003072-199903000-00006","article-title":"Diagnostic accuracy of salivary scintigraphic indices in xerostomic populations","volume":"24","year":"1999","journal-title":"Clin Nucl Med"},{"key":"bib43-20241203","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.mnm.0000202864.52046.b1","article-title":"Normal values of [99mTc]pertechnetate uptake and excretion fraction by major salivary glands","volume":"27","year":"2006","journal-title":"Nucl Med Commun"},{"key":"bib44-20241203","first-page":"38","article-title":"Study of quantitative oral radioactivity in salivary gland scintigraphy and determination of the clinical stage of Sjogren's syndrome","volume":"42","year":"2001","journal-title":"J Nucl Med"},{"key":"bib45-20241203","first-page":"81","article-title":"Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance","volume":"31","year":"2003","journal-title":"J Nucl Med Technol"},{"key":"bib46-20241203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0901-5027(88)80151-6","article-title":"Scintigraphic evaluation of the salivary glands in patients with Sjogren's syndrome","volume":"17","year":"1988","journal-title":"Int J Oral Maxillofac Surg"},{"key":"bib47-20241203","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/03009749409099282","article-title":"Salivary gland scintigraphy in subjects with and without symptoms of dry mouth and\/or eyes, and in patients with primary Sjogren's syndrome","volume":"23","year":"1994","journal-title":"Scand J Rheumatol"},{"key":"bib48-20241203","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"bib49-20241203","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1136\/annrheumdis-2014-206683","article-title":"The SSB-positive\/SSA-negative antibody profile is not associated with key phenotypic features of Sjogren's syndrome","volume":"74","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"bib50-20241203","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/MNM.0000000000000983","article-title":"Validation of quantitative salivary gland scintigraphy in relation to the American-European concensus criteria for Sjogren's syndrome","volume":"40","year":"2019","journal-title":"Nucl Med Commun"},{"key":"bib51-20241203","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10067-007-0783-y","article-title":"Anti-SSB\/La antibody is negatively associated with HLA-DR2 in chronic hepatitis C infection","volume":"27","year":"2008","journal-title":"Clin Rheumatol"},{"key":"bib52-20241203","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS-A\/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis","volume":"26","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"bib53-20241203","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/annrheumdis-2011-200460","article-title":"Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjogren's syndrome treated with rituximab","volume":"71","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"bib54-20241203","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10067-007-0586-1","article-title":"Quantitative salivary gland scintigraphy can distinguish patients with primary Sjogren's syndrome during the evaluation of sicca symptoms","volume":"26","year":"2007","journal-title":"Clin Rheumatol"},{"key":"bib55-20241203","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3899\/jrheum.081267","article-title":"Diagnostic value of salivary gland ultrasonographic scoring system in primary Sjogren's syndrome: a comparison with scintigraphy and biopsy","volume":"36","year":"2009","journal-title":"J Rheumatol"},{"key":"bib56-20241203","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jcla.21545","article-title":"Is identification of anti-SSA and\/or -SSB antibodies necessary in serum samples referred for antinuclear antibodies testing?","volume":"26","year":"2012","journal-title":"J Clin Lab Anal"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T18:06:35Z","timestamp":1733249195000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":55,"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005602","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,3]]}}}